Clinical Trial Update: Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 study comparing olmesartan medoxomil with losartan potassium for essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Losartan Potassium (Losartan potassium)
• OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED